Duvvuri et al.12 reported an association of ANO1 expression with decreased survival in HNSCC patients, although using a small sample size n = 34 and non-commercial antibodies, detecting ANO1 overexpression in 80% cases. Here, ANO1 is linked to head and neck squamous cell carcinoma.